Smash and DASH with Cas9 by unknown
Ramani and Shendure Genome Biology  (2016) 17:42 
DOI 10.1186/s13059-016-0905-4RESEARCH HIGHLIGHT Open AccessSmash and DASH with Cas9
Vijay Ramani1* and Jay Shendure1,2*
Please see related Research article: http://dx.doi.org/10.1186/s13059-016-0904-5Abstract
DeRisi and colleagues present a creative application for
Cas9 in vitro, using it to deplete unwanted sequence
from DNA libraries. It seems plausible that the in vitro
use of CRISPR/Cas9 has unrealized potential to
revolutionize the practice of molecular biology well
beyond genome editing.target sequences. For example, RNase H-based methodsCas9 as a molecular biological tool
Programmed cleavage of DNA by clustered regularly
interspersed palindromic repeats (CRISPR)/Cas9 has
been a transformative development in biomedical re-
search [1]. Short guide RNA (sgRNA) libraries have
quickly overtaken small hairpin RNA (shRNA) libraries
as the de facto functional genomics tool, and the ease
with which Cas9 enables genome perturbation both in
single clones and in high-throughput is revolutionizing
the way biologists approach their craft [2]. However, the
potential utility of Cas9 as a more general reagent for
molecular biology has received far less attention.
In this issue of Genome Biology, DeRisi and colleagues
describe depletion of abundant sequences by
hybridization — or DASH — a novel molecular tech-
nique that employs the inherent programmability of the
Cas9 nuclease to perform in vitro depletion of
unwanted library molecules prior to PCR amplification
[3]. The authors provide proof-of-concept for this
method, applying it in the contexts of massively parallel
sequencing and digital droplet PCR (ddPCR) experiments.DASHing away unwanted molecules
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cations (for example, RNA-seq) where sensitivity is
often important, yet abundant unwanted sequences
like ribosomal RNA (rRNA) and small nucleolar
RNAs (snoRNAs) comprise a large fraction of sampled
molecules. There are currently several approaches for
addressing this issue, nearly all of which rely on
hybridization of sequence-specific oligonucleotides to
for rRNA depletion use the heteroduplex-specific RNase
H to digest away RNA–DNA hybrids in a targeted way,
but are limited to RNA applications. Hybrid capture
and subtractive hybridization, which employ streptavi-
din pull-down of biotinylated hybridization probes [4], are
applicable to any single-stranded or double-stranded
library of DNA molecules, but are time-intensive, typically
require large amounts of starting material, and are expen-
sive when purchased as kits.
The DASH method presents a novel, robust alternative
to the current suite of tools for targeted sequence
depletion. In DASH, sgRNA libraries tiling over
undesired regions are designed and T7-transcribed
in vitro from a pool of double-stranded DNA templates.
Cas9 ribonucleoprotein complexes are then assembled
and incubated with DNA libraries, digesting unwanted
molecules and preventing them from acting as viable
PCR templates.
The authors demonstrate DASH in three contexts:
first, to deplete mitochondrial rRNA sequence in low-
input RNA-seq libraries from HeLa total RNA; second, to
deplete mitochondrial rRNA sequence to aid sequence-
based pathogen detection in patient cerebrospinal fluid
(CSF); and third, to increase the relative abundance of a
known driver KRAS mutation with respect to wild-type
sequence in a synthetic genomic DNA (gDNA) mixture.
The efficiency of DASH in each context is striking. In
HeLa libraries, mitochondrial rRNA contamination
dropped from a 61 % to a miniscule 0.055 % of uniquely
mapped sequencing reads. In libraries generated using
CSF from a patient with meningoencephalitis, the authors
observed a twofold to fourfold increase in pathogen-This article is distributed under the terms of the Creative Commons Attribution
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infectious agents. Finally, when using DASH to
deplete wild-type KRAS sequence in synthetic gDNA
mixtures prior to molecule counting on a ddPCR
platform, the authors observed 10- to 65-fold enrich-
ment for the mutant KRAS allele of interest, further
highlighting the versatility of their approach.
A common worry with many Cas9 applications is
the relative fidelity of the nuclease, particularly in
cases where vast molar excesses of enzyme are used
with respect to targets [5]. In this regard, one encour-
aging result presented by the authors is the relatively
small effect of off-target cleavage when using DASH.
While this is likely as much a function of the gRNAs
selected as it is a general feature of the protocol it-
self, it is reassuring that when analyzing DASHed
HeLa RNA-seq data, the authors only detected one
off-target, which harbored strong identity to a region
of the 16S mitochondrial rRNA gene. This suggests
that with optimal gRNA design parameters, users
should not expect gross overdigestion of DNA librar-
ies due to Cas9 off-targets.
Future applications for DASH and Cas9 in vitro
DASH represents a simple, flexible approach for
depleting practically any sequence or sequences in DNA
libraries — an approach that is less costly in terms of
reagent price and raw bench time with respect to other
methods, particularly when users supply their own puri-
fied Cas9. Given this, we anticipate that DASH will find
a host of other applications. ATAC-seq [6] and single-cell
ATAC-seq [7, 8] libraries are notorious for contamination
by mitochondrial gDNA, which can comprise as many as
70 % of sequencing reads. DASHing away unwanted reads
using a tiling library of mitochondrial genome-specific
sgRNAs seems a potentially straightforward solution to
minimizing these unwanted reads. DASH could also facili-
tate the efficiency of single cell RNAseq— abundant poly-
adenylated transcripts (for example, GAPDH, actin) could
be depleted from libraries, enabling higher coverage of
other transcripts of interest across large numbers of cells.
We are also intrigued by the myriad other potential
applications for in vitro Cas9 digestion. While the
authors chose to focus on using Cas9 as a reagent for
depletion, their experiments to deplete wild-type KRAS
alleles suggest other possibilities. For example, by gener-
ating libraries containing guides overlapping known
polymorphisms one could use in vitro Cas9 digestion to
enrich for sequences in a haplotype-specific manner.
Also, by taking advantage of decreasing oligosynthesis
costs [9], one could conceivably multiplex DASH-like
experiments, using pools of many thousands of gRNAs
per experiment to precisely cleave and enrich for desired
sequences at scale.In vitro Cas9 applications need not necessarily involve
digestion. Recent work has suggested that nuclease-dead
Cas9 variants (dCas9) can be used in cells to enrich
for genomic regions through a chromatin immuno-
precipitation assay termed enChIP [10]. While specu-
lative, one could imagine in vitro experiments where
epitope-tagged dCas9 is pulled-down following incu-
bation with sequencing libraries; such an assay could
be used for sequence enrichment, for example in
instances where genomic insertion events (for ex-
ample, retrotransposition, lentiviral integration) must
be mapped.
Closing remarks
A more general point is that restriction enzymes are
utterly central to molecular biology (for instance cloning),
but their range and specificity are inherently limited by
the repertoire of what has evolved in microorganisms. In
vitro Cas9 digestion remediates this through complete
programmability of cleavage, a fact that has received too
little billing given excitement about genome editing. As
such, the application space pioneered by DeRisi and
colleagues has the potential to revolutionize how we
practice molecular biology on a daily basis.
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